These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1688228)

  • 41. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
    Uchida T; Wada K; Akamatsu T; Yonezawa M; Noguchi H; Mizoguchi A; Kasuga M; Sakamoto C
    Biochem Biophys Res Commun; 1999 Dec; 266(2):593-602. PubMed ID: 10600548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the betacellulin receptor in pancreatic AR42J cells.
    Ishiyama N; Kanzaki M; Seno M; Yamada H; Kobayashi I; Kojima I
    Diabetologia; 1998 Jun; 41(6):623-8. PubMed ID: 9662041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines.
    al Moustafa AE; Alaoui-Jamali M; Paterson J; O'Connor-McCourt M
    Anticancer Res; 1999; 19(1A):481-6. PubMed ID: 10226586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME
    Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
    Staebler A; Sommers C; Mueller SC; Byers S; Thompson EW; Lupu R
    Breast Cancer Res Treat; 1994; 31(2-3):175-82. PubMed ID: 7881097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R; Dickson RB; Lippman ME
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):229-36. PubMed ID: 1356015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma.
    Cohen BD; Siegall CB; Bacus S; Foy L; Green JM; Hellström I; Hellström KE; Fell HP
    Biochem Soc Symp; 1998; 63():199-210. PubMed ID: 9513724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene.
    Langton BC; Crenshaw MC; Chao LA; Stuart SG; Akita RW; Jackson JE
    Cancer Res; 1991 May; 51(10):2593-8. PubMed ID: 1673637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2.
    Xu X; Kelleher KF; Liao J; Creek KE; Pirisi L
    Oncogene; 2000 Jun; 19(28):3172-81. PubMed ID: 10918572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
    Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
    Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.
    Marikovsky M; Lavi S; Pinkas-Kramarski R; Karunagaran D; Liu N; Wen D; Yarden Y
    Oncogene; 1995 Apr; 10(7):1403-11. PubMed ID: 7731691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
    Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS
    Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines.
    Saceda M; Grunt TW; Colomer R; Lippman ME; Lupu R; Martin MB
    Endocrinology; 1996 Oct; 137(10):4322-30. PubMed ID: 8828492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence.
    Ignatoski KM; Lapointe AJ; Radany EH; Ethier SP
    Endocrinology; 1999 Aug; 140(8):3615-22. PubMed ID: 10433219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
    Lupu R; Colomer R; Kannan B; Lippman ME
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2287-91. PubMed ID: 1347947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
    Modjtahedi H; Styles JM; Dean CJ
    Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth factor-regulated pathways in epithelial cell proliferation.
    Aaronson SA; Rubin JS; Finch PW; Wong J; Marchese C; Falco J; Taylor WG; Kraus MH
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S7-10. PubMed ID: 2252277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
    Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
    Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities.
    Puddicombe SM; Wood L; Chamberlin SG; Davies DE
    J Biol Chem; 1996 Nov; 271(48):30392-7. PubMed ID: 8940002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.
    Tzahar E; Moyer JD; Waterman H; Barbacci EG; Bao J; Levkowitz G; Shelly M; Strano S; Pinkas-Kramarski R; Pierce JH; Andrews GC; Yarden Y
    EMBO J; 1998 Oct; 17(20):5948-63. PubMed ID: 9774339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.